MNCLHD

MNCLHD

16 March 2017

Cardiometabolic comorbidities, readmission, and costs in schizophrenia and bipolar disorder

Mental illnesses are associated with increased risk of cardiometabolic comorbidities. In this study, Correll et al. evaluate the prevalence of these comorbidities, hospitalisation outcomes and costs among patients with schizophrenia and bipolar disorder. They find that more than 60% of inpatients with these disorders also have cardiometabolic comorbidities, and that increased comorbidity burden was associated with greater likelihood of readmission.

Christoph U. Correll, Daisy S. Ng-MakDana Stafkey-Mailey, Eileen Farrelly, Krithika Rajagopalan and Antony Loebel. (2017). Cardiometabolic comorbidities, readmission, and costs in schizophrenia and bipolar disorder: a real-world analysis. Annals of General Psychiatry, 16(9)   
 

No comments: